http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 12 Dec 2025 17:24:00 -0500 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Axe+Compute+Inc.+++++++++++++++++++++/25735671.html si-local-file:///var/storage/secattach/20251212/25735671.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Axe+Compute+Inc.+++++++++++++++++++++/25735671.html Fri, 12 Dec 2025 17:24:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Axe+Compute+Inc.+++++++++++++++++++++/25735671.html si-local-file:///var/storage/secattach/20251212/25735671.html http://www.streetinsider.com/SEC+Filings/Form++S-8++++++++Axe+Compute+Inc.+++++++++++++++++++++/25735671.html Fri, 12 Dec 2025 17:24:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Axe+Compute+Inc.++++++++++For%3A+Dec+10/25735623.html si-local-file:///var/storage/secattach/20251212/25735623.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Axe+Compute+Inc.++++++++++For%3A+Dec+10/25735623.html Fri, 12 Dec 2025 17:18:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Axe+Compute+Inc.++++++++++For%3A+Dec+10/25735623.html si-local-file:///var/storage/secattach/20251212/25735623.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Axe+Compute+Inc.++++++++++For%3A+Dec+10/25735623.html Fri, 12 Dec 2025 17:18:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+09/25726050.html si-local-file:///var/storage/secattach/20251211/25726050.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+09/25726050.html Thu, 11 Dec 2025 06:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+09/25726050.html si-local-file:///var/storage/secattach/20251211/25726050.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+09/25726050.html Thu, 11 Dec 2025 06:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Predictive+Oncology+Inc.++For%3A+Nov+28++Filed+by%3A+Vennare+Raymond+F/25690593.html si-local-file:///var/storage/secattach/20251202/25690593.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Predictive+Oncology+Inc.++For%3A+Nov+28++Filed+by%3A+Vennare+Raymond+F/25690593.html Tue, 02 Dec 2025 18:03:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Predictive+Oncology+Inc.++For%3A+Nov+28++Filed+by%3A+Vennare+Raymond+F/25690593.html si-local-file:///var/storage/secattach/20251202/25690593.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Predictive+Oncology+Inc.++For%3A+Nov+28++Filed+by%3A+Vennare+Raymond+F/25690593.html Tue, 02 Dec 2025 18:03:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+01/25690332.html si-local-file:///var/storage/secattach/20251202/25690332.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+01/25690332.html Tue, 02 Dec 2025 17:15:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+01/25690332.html si-local-file:///var/storage/secattach/20251202/25690332.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Dec+01/25690332.html Tue, 02 Dec 2025 17:15:00 -0500 O.10991912 POAI http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+Nasdaq+compliance+with+equity+requirement/25686082.html <p>Predictive Oncology Inc. (NASDAQ: POAI) received notification from Nasdaq on December 1 that it regained compliance with the exchange's minimum stockholders' equity requirement of $2.5 million, according to a company statement.</p> <p>The AI-driven drug discovery company will continue trading on the Nasdaq Capital Market under ticker "POAI" after meeting the requirement outlined in Nasdaq Listing Rule 5550(b)(1).</p> <p>"Regaining compliance with Nasdaq's ongoing listing requirements reflects our recent progress in strengthening the Company's financial position and preserving investor confidence in our long-term vision," stated Josh Blacher, Chief Financial Officer of Predictive Oncology.</p> <p>The Pittsburgh-based company operates an AI platform called PEDAL that predicts with http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+Nasdaq+compliance+with+equity+requirement/25686082.html Tue, 02 Dec 2025 08:01:25 -0500 O.10991912 POAI http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+Nasdaq+compliance+with+equity+requirement/25686082.html <p>Predictive Oncology Inc. (NASDAQ: POAI) received notification from Nasdaq on December 1 that it regained compliance with the exchange's minimum stockholders' equity requirement of $2.5 million, according to a company statement.</p> <p>The AI-driven drug discovery company will continue trading on the Nasdaq Capital Market under ticker "POAI" after meeting the requirement outlined in Nasdaq Listing Rule 5550(b)(1).</p> <p>"Regaining compliance with Nasdaq's ongoing listing requirements reflects our recent progress in strengthening the Company's financial position and preserving investor confidence in our long-term vision," stated Josh Blacher, Chief Financial Officer of Predictive Oncology.</p> <p>The Pittsburgh-based company operates an AI platform called PEDAL that predicts with http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+Nasdaq+compliance+with+equity+requirement/25686082.html Tue, 02 Dec 2025 08:01:25 -0500 O.10991912 POAI http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+NASDAQ+compliance+with+equity+requirement/25686057.html <p>Predictive Oncology Inc. (NASDAQ: POAI) announced it received notification from Nasdaq on December 1, 2025, confirming the company regained compliance with the exchange's minimum stockholders' equity requirement of $2.5 million.</p> <p>The Pittsburgh-based company said its shares will continue trading on the Nasdaq Capital Market under the ticker "POAI" following compliance with Nasdaq Listing Rule 5550(b)(1).</p> <p>"Regaining compliance with Nasdaq's ongoing listing requirements reflects our recent progress in strengthening the Company's financial position and preserving investor confidence in our long-term vision," stated Josh Blacher, Chief Financial Officer of Predictive Oncology.</p> <p>Predictive Oncology operates an AI-driven drug discovery platform called PEDAL, which the company states http://www.streetinsider.com/Corporate+News/Predictive+Oncology+regains+NASDAQ+compliance+with+equity+requirement/25686057.html Tue, 02 Dec 2025 08:01:03 -0500 POAI http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%27s+Minimum+Stockholders%27+Equity+Requirement/25685857.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq's minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%27s+Minimum+Stockholders%27+Equity+Requirement/25685857.html Tue, 02 Dec 2025 08:00:00 -0500 POAI http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%27s+Minimum+Stockholders%27+Equity+Requirement/25685857.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq's minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders' equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%27s+Minimum+Stockholders%27+Equity+Requirement/25685857.html Tue, 02 Dec 2025 08:00:00 -0500 POAI http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq&apos;s minimum stockholders&apos; equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders&apos; equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html Tue, 02 Dec 2025 08:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq&apos;s minimum stockholders&apos; equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders&apos; equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Press+Releases/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html Tue, 02 Dec 2025 08:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq&apos;s minimum stockholders&apos; equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders&apos; equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html Tue, 02 Dec 2025 08:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html <p>PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq&apos;s minimum stockholders&apos; equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders&apos; equity of at least $2,500,000. As a result, the Company’s shares will continue to trade on the http://www.streetinsider.com/Globe+Newswire/Predictive+Oncology+Regains+Compliance+with+Nasdaq%26apos%3Bs+Minimum+Stockholders%26apos%3B+Equity+Requirement/25685993.html Tue, 02 Dec 2025 08:00:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Predictive+Oncology+Inc.+++++++++++++/25665990.html si-local-file:///var/storage/secattach/20251126/25665990.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Predictive+Oncology+Inc.+++++++++++++/25665990.html Wed, 26 Nov 2025 06:06:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Predictive+Oncology+Inc.+++++++++++++/25665990.html si-local-file:///var/storage/secattach/20251126/25665990.html http://www.streetinsider.com/SEC+Filings/Form++EFFECT+++++Predictive+Oncology+Inc.+++++++++++++/25665990.html Wed, 26 Nov 2025 06:06:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Nov+25/25664558.html si-local-file:///var/storage/secattach/20251125/25664558.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Nov+25/25664558.html Tue, 25 Nov 2025 17:15:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Nov+25/25664558.html si-local-file:///var/storage/secattach/20251125/25664558.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Predictive+Oncology+Inc.++For%3A+Nov+25/25664558.html Tue, 25 Nov 2025 17:15:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Predictive+Oncology+Inc.+++++++++++++/25664420.html si-local-file:///var/storage/secattach/20251125/25664420.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Predictive+Oncology+Inc.+++++++++++++/25664420.html Tue, 25 Nov 2025 17:04:00 -0500 O.10991912 POAI http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Predictive+Oncology+Inc.+++++++++++++/25664420.html si-local-file:///var/storage/secattach/20251125/25664420.html http://www.streetinsider.com/SEC+Filings/Form++424B3++++++Predictive+Oncology+Inc.+++++++++++++/25664420.html Tue, 25 Nov 2025 17:04:00 -0500 O.10991912 POAI